Synovial Fibroblast 1: Secretion response of primary human synovial fibroblast samples from one healthy and one rheumatoid arthritis donor to a panel of 10 stimuli and 10 small molecule inhibitors - Dataset (ID:20233)
- Detail
- Small Molecules Studied
- Primary Cells Studied
- Proteins Studied
- Unclassified Perturbagens Studied
- Data Columns
- Results
Download: Excel (XLSX), Comma-separated (CSV)
Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | Protein Stimulus | Other Stimulus | Stimulus Concentration | Stimulus Conc Unit | ExpPlate | Measured Protein | Measured Protein MFI (a.u.) | Bead Count |
---|---|---|---|---|---|---|---|---|---|---|---|
N2586 | IKK16 | 2.0 | uM | 1 | FGF Basic | 37.0 | 42 | ||||
N2586 | 1 | FGF Basic | 44.0 | 33 | |||||||
0 | FGF Basic | 41.0 | 55 | ||||||||
0 | FGF Basic | 32.0 | 39 | ||||||||
RA2159 | TNF-a | 100 | ng/mL | 1 | FGF Basic | 64.0 | 52 | ||||
RA2159 | PD184352 | 0.1 | uM | TNF-a | 100 | ng/mL | 1 | FGF Basic | 51.0 | 60 | |
RA2159 | Lestaurtinib | 0.3 | uM | TNF-a | 100 | ng/mL | 1 | FGF Basic | 58.0 | 81 | |
RA2159 | Ruxolitinib | 0.3 | uM | TNF-a | 100 | ng/mL | 1 | FGF Basic | 56.0 | 53 | |
RA2159 | Tofacitinib | 0.3 | uM | TNF-a | 100 | ng/mL | 1 | FGF Basic | 54.5 | 64 | |
RA2159 | IKK16 | 2.0 | uM | TNF-a | 100 | ng/mL | 1 | FGF Basic | 54.0 | 64 | |
RA2159 | EO1428 | 1.0 | uM | 1 | FGF Basic | 40.0 | 77 | ||||
N2586 | TNF-a | 100 | ng/mL | 1 | FGF Basic | 59.0 | 73 | ||||
N2586 | PD184352 | 0.1 | uM | TNF-a | 100 | ng/mL | 1 | FGF Basic | 63.5 | 62 | |
N2586 | Lestaurtinib | 0.3 | uM | TNF-a | 100 | ng/mL | 1 | FGF Basic | 70.0 | 63 | |
N2586 | Ruxolitinib | 0.3 | uM | TNF-a | 100 | ng/mL | 1 | FGF Basic | 60.5 | 62 | |
N2586 | Tofacitinib | 0.3 | uM | TNF-a | 100 | ng/mL | 1 | FGF Basic | 54.0 | 46 | |
N2586 | IKK16 | 2.0 | uM | TNF-a | 100 | ng/mL | 1 | FGF Basic | 64.0 | 63 | |
N2586 | EO1428 | 1.0 | uM | 1 | FGF Basic | 66.5 | 36 | ||||
RA2159 | IL-1 alpha | 100 | ng/mL | 1 | FGF Basic | 52.0 | 79 | ||||
RA2159 | PD184352 | 0.1 | uM | IL-1 alpha | 100 | ng/mL | 1 | FGF Basic | 47.0 | 87 | |
RA2159 | Lestaurtinib | 0.3 | uM | IL-1 alpha | 100 | ng/mL | 1 | FGF Basic | 46.0 | 62 | |
RA2159 | Ruxolitinib | 0.3 | uM | IL-1 alpha | 100 | ng/mL | 1 | FGF Basic | 55.5 | 78 | |
RA2159 | Tofacitinib | 0.3 | uM | IL-1 alpha | 100 | ng/mL | 1 | FGF Basic | 54.0 | 72 | |
RA2159 | IKK16 | 2.0 | uM | IL-1 alpha | 100 | ng/mL | 1 | FGF Basic | 37.0 | 80 | |
RA2159 | PI103 | 0.1 | uM | 1 | FGF Basic | 38.0 | 73 |